ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,399Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 315

$999K Total Retail Price of All Prescriptions

Rank: 11 out of 315

348 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 9,218 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$96 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
CRESTOR 398 353 1 24
LIDODERM 278 248 2 76
SIMVASTATIN 259 221 3 1
OMEPRAZOLE 256 227 4 9
EXFORGE 246 229 5 107
JANUMET 242 229 6 83
LOVAZA 227 199 7 64
CELEBREX 226 214 8 34
LOSARTAN POTASSIUM 226 194 8 4
ATELVIA 201 201 10 102
DIOVAN HCT 198 160 11 56
TRIAMCINOLONE ACETONIDE 194 150 12 62
ATORVASTATIN CALCIUM 186 171 13 5
CLOPIDOGREL 180 171 14 25
GLYBURIDE-METFORMIN HCL 176 142 R 15 87
LOSARTAN-HYDROCHLOROTHIAZIDE 162 151 16 17
DIOVAN 158 148 17 27
TAMSULOSIN HCL 153 151 18 21
ZOLPIDEM TARTRATE 136 104 19 29
PLAVIX 135 129 20 40
GLIMEPIRIDE 130 127 21 32
RANITIDINE HCL 125 114 22 42
TRAMADOL HCL-ACETAMINOPHEN 125 123 22 123
BYSTOLIC 123 123 24 73
NEXIUM 122 107 25 54
CLOBETASOL PROPIONATE 118 109 26 82
SPIRIVA 117 99 27 74
AMOXICILLIN 109 91 28 65
LEVOTHYROXINE SODIUM 109 98 28 6
MICARDIS HCT 108 108 30 256
METFORMIN HCL 108 73 30 7
EVISTA 103 103 32 48
FLUTICASONE PROPIONATE 95 67 33 53
ALLOPURINOL 93 93 34 14
MECLIZINE HCL 93 80 34 81
HYDROXYZINE HCL 90 72 R 36 105
AVODART 87 74 37 113
KOMBIGLYZE XR 84 82 38 172
PRAVASTATIN SODIUM 80 80 39 10
FUROSEMIDE 75 63 40 15
LANSOPRAZOLE 75 69 40 286
BENICAR HCT 74 66 42 126
CEFDINIR 72 69 43 195
HYDROCODONE-ACETAMINOPHEN 71 71 S3 44 19
TRAMADOL HCL 67 62 45 59
MELOXICAM 67 60 45 77
FINASTERIDE 66 66 47 60
DONEPEZIL HCL 63 63 48 28
BENICAR 62 62 49 80
LOPERAMIDE 57 56 50 159
ACTOPLUS MET 57 47 50 247
MICARDIS 56 51 52 209
AMLODIPINE BESYLATE 55 46 53 2
LISINOPRIL 54 43 54 3
SYMBICORT 53 51 55 135
LOVASTATIN 52 52 56 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.